Clinical studies have shown that the expression of ZO-1 protein in duodenal crypts and intestinal villi in patients with NAFLD is significantly lower than that in normal individuals, and is closely related to increased intestinal permeability and intestinal bacterial overgrowth [41]. Here, TJP1 is linked to metabolic dysfunction-associated steatotic liver disease.